{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042506","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2026-09-14T13:28:02+00:00","discovered_at":"2026-09-14T13:29:01.180218+00:00","generated_at":"2026-09-14T13:29:06.663417+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cardiff Oncology and Nerviano settle litigation, amend onvansertib license","bullets":["Settlement resolves Cardiff v. Nerviano (Case No. 3:26-cv-03131-RBM-JLB) with mutual releases; no money exchanged","Amended license adds exclusivity framework, additional license fee on annual net sales, and development milestones","Nerviano gets board observer plus Scientific Advisory Board seat; revised post-termination royalty tiers added","Revised assignment provision: Cardiff owes NMS percentage of proceeds if change of control before Phase III data readout","Amendment effective upon dismissal with prejudice; existing license otherwise remains in force"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042506","json":"https://secwatch.observer/filing/0001493152-26-042506.json","markdown":"https://secwatch.observer/filing/0001493152-26-042506.md","text":"https://secwatch.observer/filing/0001493152-26-042506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000149315226042506/0001493152-26-042506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000149315226042506/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T13:29:06.663417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}